{"id":"W4411469637","doi":"10.1016/j.eururo.2025.05.037","title":"Postprogression Survival of Patients with Metastatic Hormone-sensitive Prostate Cancer who Received Darolutamide or Placebo in Combination with Docetaxel and Androgen Deprivation Therapy: Post Hoc Analysis of the Phase 3 ARASENS Trial","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"Bayer","keywords":"Medicine; Docetaxel; Taxane; Hazard ratio; Internal medicine; Discontinuation; Prostate cancer; Placebo; Androgen deprivation therapy; Oncology; Post-hoc analysis; Surgery; Chemotherapy; Cancer; Confidence interval; Breast cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003474758,0.0009204118,0.002015415,0.000242892,0.0002496585,0.0008108234,0.0006880688,0.0007842103,0.002105244],"category_scores_gemma":[0.001796876,0.0003185961,0.003514319,0.0002672417,0.0005787522,0.0007441594,0.0004061503,0.001972069,0.0003131993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005868172,"about_ca_system_score_gemma":0.001130964,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000557028,"about_ca_topic_score_gemma":0.001599296,"domain_scores_codex":[0.9987538,0.0008447212,0.0000638112,0.0001554326,0.00007372189,0.0001085467],"domain_scores_gemma":[0.9985818,0.0004761447,0.0003627692,0.0001534592,0.0000769394,0.0003490804],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9628345,0.002463786,0.01494369,0.0002758594,0.003599874,0.0000548889,0.00006518268,0.0006709006,0.00183797,0.0000460002,0.0005122257,0.01269505],"study_design_scores_gemma":[0.5286316,0.3337793,0.1221489,0.0001065338,0.00785198,0.0002287074,0.0001355527,0.002635123,0.001997707,0.0003931512,0.002029278,0.0000620788],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973073,0.001513293,0.0001055689,0.0001435595,0.00007103817,0.00017603,0.0003226601,0.00001142075,0.0003490926],"genre_scores_gemma":[0.9979197,0.0004235655,0.0001570622,0.0001355459,0.00009730158,0.0001832882,0.0006656792,0.000004574675,0.0004132835],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003474758,"threshold_uncertainty_score":0.01837647,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01883576807794882,"score_gpt":0.3126071092349026,"score_spread":0.2937713411569538,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}